Parsons Capital Management Inc/Ri / TMO
Parsons Capital Management Inc/Ri’s Thermo Fisher Scientific Inc Position
Does Parsons Capital Management Inc/Ri own Thermo Fisher Scientific Inc (TMO)? Yes — 27.7K shares worth $14M (+0.62% of its 13F portfolio) as of Q1 2026, up from 21.4K shares the prior filed quarter.
Position Value
$14M
Q1 2026
Shares
27.7K
% of Portfolio
+0.62%
Quarters Held
30
currently held
Position History TMO
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 27.7K | $14M | +0.62% |
| Q4 2025 | 21.4K | $12M | +0.68% |
| Q3 2025 | 21.3K | $10M | +0.59% |
| Q2 2025 | 21.8K | $9M | +0.54% |
| Q1 2025 | 34.2K | $17M | +0.93% |
| Q4 2024 | 36.2K | $19M | +1.02% |
| Q3 2024 | 30.5K | $19M | +1.20% |
| Q2 2024 | 30.5K | $17M | +1.15% |
| Q1 2024 | 31.1K | $18M | +1.24% |
| Q4 2023 | 36.7K | $19M | +1.39% |
| Q3 2023 | 36.9K | $19M | +1.48% |
| Q2 2023 | 37.4K | $19M | +1.49% |
| Q1 2023 | 36.8K | $21M | +1.71% |
| Q4 2022 | 37.0K | $20M | +1.71% |
| Q3 2022 | 36.9K | $19M | +1.68% |
| Q2 2022 | 37.7K | $20M | +1.84% |
| Q1 2022 | 38.6K | $23M | +1.72% |
| Q4 2021 | 39.0K | $26M | +1.86% |
| Q3 2021 | 39.5K | $23M | +1.77% |
| Q2 2021 | 39.6K | $20M | +1.53% |
| Q1 2021 | 39.6K | $18M | +1.48% |
| Q4 2020 | 37.7K | $18M | +1.51% |
| Q3 2020 | 36.4K | $16M | +1.57% |
| Q2 2020 | 36.1K | $13M | +1.39% |
| Q1 2020 | 35.9K | $10M | +1.31% |
| Q4 2019 | 35.9K | $12M | +1.17% |
| Q3 2019 | 36.0K | $11M | +1.14% |
| Q2 2019 | 35.4K | $10M | +1.13% |
| Q1 2019 | 34.7K | $10M | +1.04% |
| Q4 2018 | 35.0K | $8M | +0.96% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Parsons Capital Management Inc/Ri’s full portfolio or all institutional holders of TMO.